External Fixation Versus Splinting of Acute Calcaneus Fractures

January 12, 2022 updated by: University of California, Davis

External Fixation Versus Splinting of Acute Calcaneus Fractures Prior to Definitive Surgery

Aim:

  • Determine if external fixation decreases soft tissue complications compared to splinting.
  • Determine if external fixation decreases time to definitive surgical stabilization and improves final fixation compared to splinting.
  • Determine if external fixation improves functional outcomes as evaluated by validated functional scoring systems.

Hypothesis:

  • External fixation improves definitive fixation and functional outcomes of acute calcaneal fractures with decreased complication rates compared to splinting

Study Overview

Status

Terminated

Conditions

Study Type

Interventional

Enrollment (Actual)

1

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Sacramento, California, United States, 95817
        • University of California, Davis Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 69 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Voluntary consent
  • Age 18 to 69
  • Clinical and/or advanced imaging confirming an acute calcaneal fracture that has occurred within 2 days of which, eventually definitive surgery is recommended/accepted.
  • Unable to consent

Exclusion Criteria:

  • Age <18
  • Prior surgery of the affected extremity
  • Prisoners
  • Pregnant women
  • Inflammatory arthritis
  • Non-English-speaking patients

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: External fixation
Adults diagnosed with an acute (<2 days from injury) calcaneal fracture recommended for operative treatment will be placed in external fixator until the patient is deemed clinically appropriate for definitive surgical fixation.
Patients will be placed in an external fixator followed by open versus closed surgical stabilization of their calcaneus fracture when their soft tissue is appropriate for surgery.
Active Comparator: Splinting
Adults diagnosed with an acute (<2 days from injury) calcaneal fracture recommended for operative treatment will be placed in a short leg splint until the patient is deemed clinically appropriate for definitive surgical fixation.
Patients will be placed in a short leg splint followed by open versus closed surgical stabilization of their calcaneus fracture when their soft tissue is appropriate for surgery.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to Definitive Surgery
Time Frame: Within 2 weeks from injury
Duration of time from injury to definitive surgery
Within 2 weeks from injury
Soft Tissue Complications
Time Frame: Assessed at 2 weeks after surgery
Incidence of infection, dehiscence and need for soft tissue coverage
Assessed at 2 weeks after surgery
Soft Tissue Complications
Time Frame: Assessed at 6 weeks after surgery
Incidence of infection, dehiscence and need for soft tissue coverage
Assessed at 6 weeks after surgery
Soft Tissue Complications
Time Frame: Assessed at 12 weeks after surgery
Incidence of infection, dehiscence and need for soft tissue coverage
Assessed at 12 weeks after surgery
Soft Tissue Complications
Time Frame: Assessed at 6 months after surgery
Incidence of infection, dehiscence and need for soft tissue coverage
Assessed at 6 months after surgery
Soft Tissue Complications
Time Frame: Assessed at 12 months after surgery
Incidence of infection, dehiscence and need for soft tissue coverage
Assessed at 12 months after surgery
Soft Tissue Complications
Time Frame: Assessed at 24 months after surgery
Incidence of infection, dehiscence and need for soft tissue coverage
Assessed at 24 months after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Union Rate
Time Frame: Plain xrays at 6 weeks, 12 weeks, 6 months, 1 year, and 2 years after surgery. CT scan at 1 year.
Assessment of fracture healing
Plain xrays at 6 weeks, 12 weeks, 6 months, 1 year, and 2 years after surgery. CT scan at 1 year.
Radiographic Parameters - Bohler's Angle
Time Frame: Assessed at 2, 6, & 12 weeks, and 6, 12, & 24 months after surgery
Bohler's angle
Assessed at 2, 6, & 12 weeks, and 6, 12, & 24 months after surgery
Radiographic Parameters - Calcaneal Height
Time Frame: Assessed at 2, 6, & 12 weeks, and 6, 12, & 24 months after surgery
Calcaneal height
Assessed at 2, 6, & 12 weeks, and 6, 12, & 24 months after surgery
Radiographic Parameters - Angle of Gissan
Time Frame: Assessed at 2, 6, & 12 weeks, and 6, 12, & 24 months after surgery
Angle of Gissan
Assessed at 2, 6, & 12 weeks, and 6, 12, & 24 months after surgery
Radiographic Parameters - Calcaneal Width
Time Frame: Assessed at 2, 6, & 12 weeks, and 6, 12, & 24 months after surgery
Calcaneal width
Assessed at 2, 6, & 12 weeks, and 6, 12, & 24 months after surgery
Radiographic Parameters - Calcaneal Length
Time Frame: Assessed at 2, 6, & 12 weeks, and 6, 12, & 24 months after surgery
Calcaneal length
Assessed at 2, 6, & 12 weeks, and 6, 12, & 24 months after surgery
Functional Outcomes - VAS
Time Frame: Assessed at 2, 6, & 12 weeks, and 6, 12, & 24 months after surgery.
Assess Visual Analogue pain score(VAS). This will be a patient reported measure from 0-10, minimum score of 0 (no pain), maximum score of 10 (most pain).
Assessed at 2, 6, & 12 weeks, and 6, 12, & 24 months after surgery.
Functional Outcomes - FFI-R
Time Frame: Assessed at 2, 6, & 12 weeks, and 6, 12, & 24 months after surgery
Revised foot function index questionnaire (FFI-R) will assess patient pain, stiffness, activity, difficulties with ambulation, and social issues. The score is tabulated from 34 questions answered 1-5 (1= none of the time, 5= All of the time, scale 34-170). Higher scores indicate worse outcomes.
Assessed at 2, 6, & 12 weeks, and 6, 12, & 24 months after surgery
Functional Outcomes - FAAM ADL
Time Frame: Assessed at 2, 6, & 12 weeks, and 6, 12, & 24 months after surgery
Foot and Ankle Ability measure activities of daily living (FAAM ADL) is a 21-item activities assessing the patient's functionality related to their activities of daily living. The response to each item is scored from 4 to 0, with 4 being ''no difficulty'' and 0 being ''unable to do." Scale 0-84. Higher scores indicate a more favorable functional level.
Assessed at 2, 6, & 12 weeks, and 6, 12, & 24 months after surgery
Functional Outcomes - FAAM Sport
Time Frame: Assessed at 2, 6, & 12 weeks, and 6, 12, & 24 months after surgery
Foot and Ankle Ability measure activities of daily living (FAAM Sport) is a 8-item questionnaire assess the patient's ability to participate in athletic activities. The response to each item is scored from 4 to 0, with 4 being ''no difficulty'' and 0 being ''unable to do." Scale 0-32. Higher scores indicate a more favorable functional level.
Assessed at 2, 6, & 12 weeks, and 6, 12, & 24 months after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Christopher D Kreulen, MD, MS, Foot and Ankle Surgery Department of Orthopaedic Surgery University of California, Davis Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 14, 2019

Primary Completion (Actual)

September 3, 2019

Study Completion (Actual)

September 3, 2019

Study Registration Dates

First Submitted

August 7, 2019

First Submitted That Met QC Criteria

August 19, 2019

First Posted (Actual)

August 21, 2019

Study Record Updates

Last Update Posted (Actual)

February 9, 2022

Last Update Submitted That Met QC Criteria

January 12, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 1436830

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Calcaneus Fracture

Clinical Trials on External fixator

3
Subscribe